178 related articles for article (PubMed ID: 12437133)
1. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
2. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
[TBL] [Abstract][Full Text] [Related]
3. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS
Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro.
Zagzag D; Friedlander DR; Dosik J; Chikramane S; Chan W; Greco MA; Allen JC; Dorovini-Zis K; Grumet M
Cancer Res; 1996 Jan; 56(1):182-9. PubMed ID: 8548761
[TBL] [Abstract][Full Text] [Related]
6. Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.
Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2004 Nov; 23(52):8486-96. PubMed ID: 15378018
[TBL] [Abstract][Full Text] [Related]
8. [Cathepsin B expression and malignances and angiogenesis in gliomas].
Tang JJ; Jiang S; Mao BY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):212-4, 225. PubMed ID: 16608077
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B and human tumor progression.
Yan S; Sameni M; Sloane BF
Biol Chem; 1998 Feb; 379(2):113-23. PubMed ID: 9524062
[TBL] [Abstract][Full Text] [Related]
12. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B and its inhibitor stefin A in brain tumors.
Strojnik T; Zajc I; Bervar A; Zidanik B; Golouh R; Kos J; Dolenc V; Lah T
Pflugers Arch; 2000; 439(3 Suppl):R122-3. PubMed ID: 10653164
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and localization of cathepsin B during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Wang SW; Rayford A; Yamamoto M; Liotta LA; Nicolson GL; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):49-56. PubMed ID: 7820956
[TBL] [Abstract][Full Text] [Related]
17. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
20. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.
Mai J; Waisman DM; Sloane BF
Biochim Biophys Acta; 2000 Mar; 1477(1-2):215-30. PubMed ID: 10708859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
